Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-ranging Phase I/II Study of STI571 in Combination With Cytarabin in Patients With First Chronic Phase Chronic Myeloid Leukemia

NCT00028847 is registered in ClinicalTrials.gov with Commissie Voor Klinisch Toegepast Onderzoek as lead sponsor.

NCT NCT00028847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00028847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-ranging Phase I/II Study of STI571 in Combination With Cytarabin in Patients With First Chronic Phase Chronic Myeloid Leukemia
Lead sponsor
Commissie Voor Klinisch Toegepast Onderzoek
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2001
Completion date
Not reported
Enrollment
60 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia